These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30115613)

  • 1. The mode of action of anticholinergics in asthma.
    Gosens R; Gross N
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30115613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling.
    Kistemaker LE; Gosens R
    Trends Pharmacol Sci; 2015 Mar; 36(3):164-71. PubMed ID: 25511176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergics/antimuscarinic drugs in asthma.
    Soler X; Ramsdell J
    Curr Allergy Asthma Rep; 2014 Dec; 14(12):484. PubMed ID: 25283149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
    Gosens R; Zaagsma J; Meurs H; Halayko AJ
    Respir Res; 2006 May; 7(1):73. PubMed ID: 16684353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target.
    Meurs H; Dekkers BG; Maarsingh H; Halayko AJ; Zaagsma J; Gosens R
    Pulm Pharmacol Ther; 2013 Feb; 26(1):145-55. PubMed ID: 22842340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tiotropium bromide on airway remodeling in a chronic asthma model.
    Kang JY; Rhee CK; Kim JS; Park CK; Kim SJ; Lee SH; Yoon HK; Kwon SS; Kim YK; Lee SY
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):29-35. PubMed ID: 22727154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic therapy for airway diseases.
    Jacoby DB; Fryer AD
    Life Sci; 2001 Apr; 68(22-23):2565-72. PubMed ID: 11392627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD.
    Kistemaker LE; Oenema TA; Meurs H; Gosens R
    Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing face of β2-adrenergic and muscarinic receptor therapies in asthma.
    Wasilewski NV; Lougheed MD; Fisher JT
    Curr Opin Pharmacol; 2014 Jun; 16():148-56. PubMed ID: 24922602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-neuronal cholinergic system as novel drug target in the airways.
    Pieper MP
    Life Sci; 2012 Nov; 91(21-22):1113-8. PubMed ID: 22982180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?
    Roth M
    Drugs; 2015 Jan; 75(1):1-8. PubMed ID: 25414120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions.
    Bulkhi A; Tabatabaian F; Casale TB
    Drugs; 2016 Jul; 76(10):999-1013. PubMed ID: 27289376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new perspective on muscarinic receptor antagonism in obstructive airways diseases.
    Meurs H; Oenema TA; Kistemaker LE; Gosens R
    Curr Opin Pharmacol; 2013 Jun; 13(3):316-23. PubMed ID: 23643733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergics for asthma: a long history.
    Rodrigo GJ
    Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):38-43. PubMed ID: 29040210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic receptor antagonists: effects on pulmonary function.
    Buels KS; Fryer AD
    Handb Exp Pharmacol; 2012; (208):317-41. PubMed ID: 22222705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor subtypes: implications for therapy.
    Barnes PJ
    Agents Actions Suppl; 1993; 43():243-52. PubMed ID: 8368167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic antagonists in early stage clinical development for the treatment of asthma.
    Albertson TE; Chenoweth JA; Adams JY; Sutter ME
    Expert Opin Investig Drugs; 2017 Jan; 26(1):35-49. PubMed ID: 27927039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling.
    Gosens R; Bos IS; Zaagsma J; Meurs H
    Am J Respir Crit Care Med; 2005 May; 171(10):1096-102. PubMed ID: 15695490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Muscarinic Antagonist Reduces Airway Inflammation and Bronchoconstriction Induced by Ambient Particulate Matter in a Mouse Model of Asthma.
    Kurai J; Watanabe M; Sano H; Iwata K; Hantan D; Shimizu E
    Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29882826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic treatment in airways diseases.
    Flynn RA; Glynn DA; Kennedy MP
    Adv Ther; 2009 Oct; 26(10):908-19. PubMed ID: 19967500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.